Pharma Journalist - Page 701 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

EC sanctions Celltrion’s Herzuma for breast Cancer patients

Challenges in drug-delivery device pipelines for pharma companies

Horizon Discovery enters into License Agreement with US Immuno-Oncology Company

DNAnexus Launches NGS Clinical Trial Solution

Applied Therapeutics Initiates Phase 1 Trial for AT-001 In Diabetic Complications

Teva announces Launch of a Generic Version of Syprine in the United States

LakePharma announces expansion and new MicroBiomanufacturing Center in Hopkinton, MA

Therapeutic Application of Botulinum Neurotoxin in Pain: A pre-clinical approach

Seventure Partners joins the panel at Microbiome Invest 2018

Design Principles for Maximising the Drug Delivery Efficiency & Therapeutic Index of ADCs, Presented by Seattle Genetics, at SMi’s ADC Conference